Literature DB >> 15367735

Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes.

J G Ray1, M J Vermeulen, C Meier, P R Wyatt.   

Abstract

BACKGROUND: Most studies comparing women with and without pregestational diabetes mellitus have not systematically screened for fetal anomalies in early pregnancy, potentially leading to selection bias. AIM: To evaluate the risk for certain congenital anomalies in women participating in an antenatal maternal screening program.
DESIGN: Retrospective cohort study.
METHODS: We studied all women who underwent antenatal maternal serum screening in Ontario from 1994 to 2000. Fetal anomalies were documented antenatally by ultrasonography or at autopsy, and postnatally diagnosed birth defects were recorded after 20 weeks gestational age for all live- and stillborn affected infants. We compared the risk of open neural tube defects and urinary tract defects among women with and without pregestational diabetes.
RESULTS: Of 413,219 women screened during pregnancy, 2069 (0.5%) had diabetes. Compared to non-diabetic women, the adjusted odds ratios (95%CI) for neural tube and urinary tract defects among women with diabetes were 2.5 (0.9-6.8) and 2.6 (1.4-4.9), respectively. DISCUSSION: Among women who undergo second trimester maternal serum screening, pregestational diabetes is associated with an increased risk of having a fetus with an open neural tube defect or urinary tract disorder.

Entities:  

Mesh:

Year:  2004        PMID: 15367735     DOI: 10.1093/qjmed/hch107

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  12 in total

Review 1.  Sonographic evaluation and the pregnancy complicated by diabetes.

Authors:  Jennifer M McNamara; Anthony O Odibo
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  Vasoactive exposures during pregnancy and risk of microtia.

Authors:  Carla M Van Bennekom; Allen A Mitchell; Cynthia A Moore; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-11-24

Review 3.  Preconception care of women with diabetes: a review of current guideline recommendations.

Authors:  Maimunah Mahmud; Danielle Mazza
Journal:  BMC Womens Health       Date:  2010-01-31       Impact factor: 2.809

4.  Risk factors for neural tube defects in Riyadh City, Saudi Arabia: Case-control study.

Authors:  Mustafa A M Salih; Waleed R Murshid; Ashry Gad Mohamed; Lena C Ignacio; Julie E de Jesus; Rubana Baabbad; Hassan M El Bushra
Journal:  Sudan J Paediatr       Date:  2014

Review 5.  Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Hayfaa A Wahabi; Rasmieh A Alzeidan; Samia A Esmaeil
Journal:  BMC Public Health       Date:  2012-09-17       Impact factor: 3.295

6.  Setting research priorities for preconception care in low- and middle-income countries: aiming to reduce maternal and child mortality and morbidity.

Authors:  Sohni Dean; Igor Rudan; Fernando Althabe; Aimee Webb Girard; Christopher Howson; Ana Langer; Joy Lawn; Mary-Elizabeth Reeve; Katherine C Teela; Mireille Toledano; Chandra-Mouli Venkatraman; José M Belizan; Josip Car; Kit Yee Chan; Subidita Chatterjee; Stanley Chitekwe; Tanya Doherty; France Donnay; Majid Ezzati; Khadija Humayun; Brian Jack; Zohra S Lassi; Reynaldo Martorell; Ysbrand Poortman; Zulfiqar A Bhutta
Journal:  PLoS Med       Date:  2013-09-03       Impact factor: 11.069

Review 7.  Effect of screening and management of diabetes during pregnancy on stillbirths.

Authors:  Madiha Syed; Hasan Javed; Mohammad Yawar Yakoob; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

Review 8.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 9.  Preconception care: nutritional risks and interventions.

Authors:  Sohni V Dean; Zohra S Lassi; Ayesha M Imam; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

10.  Insulin Use in Pregnancy: An Update.

Authors:  Alyson K Blum
Journal:  Diabetes Spectr       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.